WASHINGTON, Dec 3: An experimental treatment targeting hepatitis C was able to inhibit replication of the virus in the bloodstream of chimpanzees and could treat chronic infections in humans, a new study said on Thursday.
The treatment works by inhibiting a molecule that helps hepatitis C virus replicate, according to scientists at the Southwest Foundation for Biomedical Research (SFBR), who said the drug continued to work up to several months after it was used.—AFP
Thinking about ethics and current events (Began 1 April 2008)
No comments:
Post a Comment